Skip to main content
Premium Trial:

Request an Annual Quote

Quest Adds BioMerieux's BRAF Mutation Test to its Melanoma CDx Offerings

NEW YORK (GenomeWeb) – Quest Diagnostics announced today it will offer BioMérieux's BRAF mutation companion diagnostic for two of GlaxoSmithKline's molecularly targeted melanoma drugs, Tafinlar (dabrafenib) and Mekinist (trametinib).

The US Food and Drug Administration last year approved Tafinlar and Mekinist as treatments for advanced or unresectable melanoma patients whose tumors harbor certain BRAF mutations. Simultaneously, the agency approved BioMérieux's THxID-BRAF companion diagnostic, a real-time PCR assay designed to identify patients whose tumors harbor BRAF V600E and BRAF V600K mutations, and thus are best responders to these agents. Approximately half of melanoma patients have tumors driven by BRAF mutations.

Quest said in a statement that it will offer BioMérieux's test through its Dermpath and Ameripath businesses, which will expand access to more healthcare providers, including dermatologists, oncologists, and hospital pathologists. "Because Quest reaches about half of the practicing physicians and hospitals in the US, patients and providers will now have access to the THxID-BRAF test on a truly broad national scale," Frederic Waldman, medical director of cancer diagnostics at Quest, said in a statement.
In addition to BioMérieux's test, Quest offers Roche's Cobas 4800 BRAF V600 Mutation Test, which gauges which melanoma patients have BRAF V600E mutations and may receive treatment with another skin cancer agent, Zelboraf (vemurafenib). Quest also markets a Sanger sequencing-based laboratory-developed test for assessing BRAF mutations in melanoma, thyroid, and colorectal cancer patients.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.